Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
23.22
-0.46 (-1.94%)
May 29, 2026, 4:00 PM EDT - Market closed
Pacira BioSciences Employees
As of December 31, 2025, Pacira BioSciences had 829 total employees, including 825 full-time and 4 part-time employees. The number of employees increased by 39 or 4.94% compared to the previous year.
Employees
829
Change (1Y)
39
Growth (1Y)
4.94%
Revenue / Employee
$886,446
Profits / Employee
$6,198
Market Cap
913.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 829 | 39 | 4.94% | 825 | 4 |
| Dec 31, 2024 | 790 | 78 | 10.96% | 788 | 2 |
| Dec 31, 2023 | 712 | -3 | -0.42% | 711 | 1 |
| Dec 31, 2022 | 715 | 18 | 2.58% | 715 | 0 |
| Dec 31, 2021 | 697 | 73 | 11.70% | 697 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
| Collegium Pharmaceutical | 423 |
| Harrow | 373 |
PCRX News
- 1 day ago - Glass Lewis recommends shareholders vote for Pacira director nominees - TheFly
- 1 day ago - Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira's Director Nominees - GlobeNewsWire
- 1 day ago - DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION - PRNewsWire
- 2 days ago - Pacira BioSciences Proxy statement: Proxy filing - Filings
- 2 days ago - Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees - GlobeNewsWire
- 2 days ago - Pacira study shows Exparel reduces opioid use and costs - TheFly
- 3 days ago - Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty - GlobeNewsWire
- 3 days ago - Pacira BioSciences Proxy statement: Proxy filing - Filings